SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-043262
Filing Date
2021-02-16
Accepted
2021-02-16 06:38:52
Documents
1
Group Members
FORBION IV MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13G d136642dsc13g.htm SC 13G 54926
  Complete submission text file 0001193125-21-043262.txt   56392
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Subject) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91706 | Film No.: 21632196
SIC: 2834 Pharmaceutical Preparations

Mailing Address GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411 DC 31 356993000
Forbion Capital Fund IV Cooperatief U.A. (Filed by) CIK: 0001823747 (see all company filings)

IRS No.: 981445896 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G